Report date: Feb 24,2026
Conflict count: 372435
Publisher: AME Publishing Company
Title count: 22
Conflict count: 76


==========================================================

Created: 2022-04-28 23:14:35
ConfID: 6478790
CauseID: 1527855215
OtherID: 1474538202
JT: Translational Breast Cancer Research
MD: Perachino,1,,11,2020,Pyrotinib: a new promising targeted agent for human epidermal growth factor receptor 2-positive breast cancer
DOI: 10.21037/tbcr.2020-20-34(Journal) (6478790-N)
DOI: 10.21037/tbcr-20-34(Journal)
==========================================================

Created: 2026-02-03 08:37:16
ConfID: 8630199
CauseID: 1731824264
OtherID: 1731054588
JT: Translational Breast Cancer Research
MD: Yuan,7,,9,2026,Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)
DOI: 10.21037/tbcr-2025-aw-71(Journal) (8630199-N)
DOI: 10.21037/tbcr-2025-1-71(Journal)